When K.V. Rajagopalan, PhD, arrived in the United States from India to begin his postdoctoral work in the Department of Biochemistry at Duke, he familiarized himself with the department’s members by reading their journal articles. Among them were a series of papers reporting startling research on oxygen radicals by a young biochemist named Irwin Fridovich, PhD’55.

Fumiko Chino, MD, a resident in radiation oncology, last summer co-authored research showing that the high cost of cancer care is a serious problem for many patients.

When Brian Sullivan, MD was in college, his grandmother was diagnosed with colon cancer. Despite undergoing colonoscopy screenings every three years, her cancer was not identified early.

Robert Margolis is a pioneer in new models of team-based, coordinated health care, and has been on the front lines of health care reform for more than 40 years.

Juan Battle founded Elias Santana Hospital for the Poor in Santo Domingo, and took the Dominican Republic out of the dark ages of eye care.

Kafui Dzirasa’s work on neuro-engineering technologies is nothing short of revolutionary, which hold great promise for treating psychiatric illnesses.

Following in the footsteps of legendary Duke surgeon David Sabistan, current Chairman of Surgery Allan Kirk is one of the most respected transplant surgeons in the world.

Diane Havlir is a pioneer in HIV/AIDS research treatment, whose work has helped to transform HIV from a death sentence to a manageable chronic disease.

Radiation oncologist Karen Winkfield has been honored throughout the country for her research and advocacy to improve access and health outcomes for minorities.

Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers.